Xiaoguang Chen

10.1k total citations · 2 hit papers
282 papers, 8.3k citations indexed

About

Xiaoguang Chen is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Xiaoguang Chen has authored 282 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Molecular Biology, 60 papers in Oncology and 48 papers in Organic Chemistry. Recurrent topics in Xiaoguang Chen's work include Natural product bioactivities and synthesis (32 papers), Cancer therapeutics and mechanisms (21 papers) and Synthesis and biological activity (15 papers). Xiaoguang Chen is often cited by papers focused on Natural product bioactivities and synthesis (32 papers), Cancer therapeutics and mechanisms (21 papers) and Synthesis and biological activity (15 papers). Xiaoguang Chen collaborates with scholars based in China, United States and United Kingdom. Xiaoguang Chen's co-authors include Sen Zhang, Michael Chopp, Yi Li, Subhash C. Gautam, Jieli Chen, Mark Katakowski, Zhaojun Li, Chunhong Yan, Ming Ji and Yuanyuan Chen and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaoguang Chen

277 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–

2019 611 citations Yichen Liu, Tingting Du et al. profile →
Long non-coding RNAs: From disease code to drug role

2020 360 citations Xiaoguang Chen, Sen Zhang et al. profile →

Peers

Countries citing papers authored by Xiaoguang Chen

Since Specialization

Citations

This map shows the geographic impact of Xiaoguang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoguang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoguang Chen more than expected).

Fields of papers citing papers by Xiaoguang Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoguang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoguang Chen. The network helps show where Xiaoguang Chen may publish in the future.

Co-authorship network of co-authors of Xiaoguang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoguang Chen. A scholar is included among the top collaborators of Xiaoguang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoguang Chen. Xiaoguang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and Biological Evaluation of Novel Psidium Meroterpenoid Derivatives against Cisplatin-Induced Acute Kidney Injury 2024 ·Journal of Medicinal Chemistry ·Yingda Zang, (unknown), (unknown), (unknown), Chuang‐Jun Li, Jie Ma, Xiaoguang Chen, Sheng Li, Sen Zhang, Dongming Zhang	4
2	7-hydroxycoumarin-β-D-glucuronide protects against cisplatin-induced acute kidney injury via inhibiting p38 MAPK-mediated apoptosis in mice 2023 ·Life Sciences ·(unknown), Xiaohu Shi, Yingda Zang, Xiaodi Zhao, (unknown), Weida Wang, Wenying Shi, Clarence T. T. Wong, Sheng Li, Xiaoguang Chen, Sen Zhang	11
3	SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling 2023 ·International Journal of Molecular Sciences ·Weida Wang, Mingjin Wang, Tingting Du, Zhenyan Hou, (unknown), Sen Zhang, (unknown), Nina Xue, Xiaoguang Chen	18
4	Detection and identification of amphetamine-type stimulants and analogs via recognition-enabled “chromatographic” 19F NMR 2023 ·Journal of Fluorine Chemistry ·Jiayu Jiang, Lixian Wen, Hongshuang Wang, Xiaoguang Chen, Yanchuan Zhao, Xiaohui Wang	9
5	Variable p53/Nrf2 crosstalk contributes to triptolide-induced hepatotoxic process 2023 ·Toxicology Letters ·Zhenyan Hou, Miao Yan, Huixiang Li, Weida Wang, (unknown), Mingjin Wang, Tingting Du, Hui Gong, Wenqun Li, Lin Guo, Shanshan Wei, (unknown), (unknown), Xiaoguang Chen	4
6	Chlorogenic Acid Induced Neuroblastoma Cells Differentiation via the ACAT1-TPK1-PDH Pathway 2023 ·Pharmaceuticals ·(unknown), Mingjin Wang, Zhenyan Hou, Weida Wang, Tingting Du, Nina Xue, Ming Ji, Xiaoguang Chen	8
7	TCP-1, a novel peptide to diagnose early colon cancer 2023 ·Chinese Chemical Letters ·Hang Yu, Bao‐Ying Wen, Min Huang, Ru Feng, Li‐Bin Pan, (unknown), Hao Lin, Cong Lin, Sen Zhang, Yan Li, Chi‐Hin Cho, Chong‐Jing Zhang, Xiaoguang Chen, Yan Wang	0
8	S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer 2023 ·Pharmaceuticals ·Zhenyan Hou, Songwen Lin, Tingting Du, Mingjin Wang, Weida Wang, (unknown), Nina Xue, Yichen Liu, (unknown), Heng Xu, Xiaoguang Chen	2
9	Discovery of Quinazoline-2,4(1H,3H)-dione Derivatives Containing 3-Substituted Piperizines as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis 2021 ·Journal of Medicinal Chemistry ·Jie Zhou, Ming Ji, Xiaoyu Wang, Hailong Zhao, Ran Cao, Jing Jin, Yan Li, Xianhong Chen, Sheng Li, Xiaoguang Chen, Bailing Xu	20
10	Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies 2020 ·European Journal of Medicinal Chemistry ·Yingda Zang, Fangfang Lai, (unknown), Chuang‐Jun Li, Jie Ma, Chengjuan Chen, Ke Liu, Tiantai Zhang, Xiaoguang Chen, Dongming Zhang	25
11	Sphingosine-1-Phosphate Receptor Subtype 1 (S1P1) Modulator IMMH001 Regulates Adjuvant- and Collagen-Induced Arthritis 2019 ·Frontiers in Pharmacology ·Jing Jin, Ming Ji, Rong Fu, Mingjin Wang, Nina Xue, Qiong Xiao, (unknown), Xiaojian Wang, Fangfang Lai, Dali Yin, Xiaoguang Chen	13
12	Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), Jing Jin, Hualong Chen, Ran Cao, Xiaoguang Chen, Bailing Xu	25
13	Design, synthesis and biological evaluation of novel indolin-2-ones as potent anticancer compounds 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Lei Yan, Fangfang Lai, Xiaoguang Chen, Masuo Goto, Kuo‐Hsiung Lee, Zhiyan Xiao	16
14	A Synthetic Manassantin A Derivative Inhibits Hypoxia-Inducible Factor 1 and Tumor Growth 2014 ·PLoS ONE ·Liwei Lang, Xiaoyu Liu, Yan Li, Qing Zhou, Ping Xie, Chunhong Yan, Xiaoguang Chen	19
15	DEDD Interacts with PI3KC3 to Activate Autophagy and Attenuate Epithelial–Mesenchymal Transition in Human Breast Cancer 2012 ·Cancer Research ·Qi Lv, Wei Wang, Jianfei Xue, Fang Hua, Rong Mu, Heng Lin, Jun Yan, Xiaoxi Lv, Xiaoguang Chen, Zhuo-Wei Hu	141
16	Synthesis and biological evaluation of novel human Pin1 inhibitors with benzophenone skeleton 2012 ·Bioorganic & Medicinal Chemistry ·Chang Liu, Jing Jin, Chen Liang, Jie Zhou, Xiaoguang Chen, (unknown), Hongrui Song, Bailing Xu	21
17	Activity of the potent dual Abl/Src tyrosine kinase inhibitor FB2 against Bcr–Abl positive cell lines in vitro and in vivo 2010 ·Leukemia Research ·(unknown), Yi Zhang, Haijing Zhang, Jing Jin, Xiangyan Li, He Liu, Zhiqiang Feng, Xiaoguang Chen	4
18	Activity of FB2, a novel dual Abl/Src tyrosine kinase inhibitor, against imatinib-resistant chronic myeloid leukemiain vivoandin vitro 2009 ·Leukemia & lymphoma ·He Liu, Hongyan Li, Zhiqiang Feng, Jun Tai, Meng Yang, Hongbo Wang, Hongqi Xin, Sen Zhang, Mingxin Zuo, Yan Zhang, Xiaoguang Chen	4
19	Bone marrow stromal cells induce BMP2/4 production in oxygen‐glucose‐deprived astrocytes, which promotes an astrocytic phenotype in adult subventricular progenitor cells 2006 ·Journal of Neuroscience Research ·Hongqi Xin, Yi Li, Xiaoguang Chen, Michael Chopp	46
20	L-519, a phenolic compound, inhibits metabolism of benzo(a)pyrene and mutagenesis induced by benzo(a)pyrene 1995 ·Chinese Journal of Cancer Research ·Xiaoguang Chen, Zhao-Di Fu, Rui Han	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact